A Clinical Trial of Safety and Efficacy of Fasudil in Subjects With Amyotrophic Lateral Sclerosis (ALS)

Clinical trial NCT01935518 · UNKNOWN

Trial details

NCT number: NCT01935518
Sponsor: Peking University Third Hospital
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Amyotrophic Lateral Sclerosis

Start date: 2013-09-01
Primary completion: 2015-03-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.